Corient Private Wealth
KRYS icon

Corient Private Wealth’s Krystal Biotech KRYS Stock Holding History

Corient Private Wealth’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$818K Sell
3,523
-73,113
-95% -$19.5M ﹤0.01% 1762
2025
Q4 		$19M Buy
76,636
+37,506
+96% +$7.89M 0.01% 579
2025
Q3 		$6.92M Sell
39,130
-1,408
-3% -$211K 0.01% 610
2025
Q2 		$5.57M Sell
40,538
-1,589
-4% -$233K 0.01% 672
2025
Q1 		$7.6M Sell
42,127
-882
-2% -$148K 0.01% 576
2024
Q4 		$6.74M Sell
43,009
-4,678
-10% -$830K 0.01% 617
2024
Q3 		$8.68M Sell
47,687
-17,313
-27% -$3.34M 0.01% 600
2024
Q2 		$11.9M Buy
65,000
+29,028
+81% +$4.87M 0.02% 486
2024
Q1 		$6.4M Buy
+35,972
New +$5M 0.01% 642

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return